Presepsin teardown- pitfalls of biomarkers in the diagnosis and prognosis of bacterial infection in cirrhosis
|
摘要
AIM To evaluate the diagnostic and prognostic value of presepsin in cirrhosis-associated bacterial infections. METHODS Two hundred and sixteen patients with cirrhosis were enrolled. At admission, the presence of bacterial infections and level of plasma presepsin, serum C-reactive protein(CRP) and procalcitonin(PCT) were evaluated. Patients were followed for three months to assess the possible association between presepsin level and short-term mortality.RESULTS Present 34.7 of patients had bacterial infection. Presepsin levels were significantly higher in patients with infection than without(median, 1002 pg/m L vs 477 pg/m L, P < 0.001), increasing with the severity of infection [organ failure(OF): Yes vs No, 2358 pg/m L vs 710 pg/m L, P < 0.001]. Diagnostic accuracy of presepsin for severe infections was similar to PCT and superior to CRP(AUC-ROC: 0.85, 0.85 and 0.66, respectively, P = NS for presepsin vs PCT and P < 0.01 for presepsin vs CRP). At the optimal cut-off value of presepsin > 1206 pg/m L sensitivity, specificity, positive predictive values and negative predictive values were as follows: 87.5%, 74.5%, 61.8% and 92.7%. The accuracy of presepsin, however, decreased in advanced stage of the disease or in the presence of renal failure, most probably because of the significantly elevated presepsin levels in non-infected patients. 28-d mortality rate was higher among patients with > 1277 pg/m L compared to those with ≤ 1277 pg/m L(46.9% vs 11.6%, P < 0.001). In a binary logistic regression analysis, however, only PCT(OR = 1.81, 95%CI: 1.09-3.01, P = 0.022) but neither presepsin nor CRP were independent risk factor for 28-d mortality after adjusting with MELD score and leukocyte count.CONCLUSION Presepsin is a valuable new biomarker for defining severe infections in cirrhosis, proving same efficacy as PCT. However, it is not a useful marker of short-term mortality.
AIM To evaluate the diagnostic and prognostic value of presepsin in cirrhosis-associated bacterial infections. METHODS Two hundred and sixteen patients with cirrhosis were enrolled. At admission, the presence of bacterial infections and level of plasma presepsin, serum C-reactive protein(CRP) and procalcitonin(PCT) were evaluated. Patients were followed for three months to assess the possible association between presepsin level and short-term mortality.RESULTS Present 34.7 of patients had bacterial infection. Presepsin levels were significantly higher in patients with infection than without(median, 1002 pg/m L vs 477 pg/m L, P < 0.001), increasing with the severity of infection [organ failure(OF): Yes vs No, 2358 pg/m L vs 710 pg/m L, P < 0.001]. Diagnostic accuracy of presepsin for severe infections was similar to PCT and superior to CRP(AUC-ROC: 0.85, 0.85 and 0.66, respectively, P = NS for presepsin vs PCT and P < 0.01 for presepsin vs CRP). At the optimal cut-off value of presepsin > 1206 pg/m L sensitivity, specificity, positive predictive values and negative predictive values were as follows: 87.5%, 74.5%, 61.8% and 92.7%. The accuracy of presepsin, however, decreased in advanced stage of the disease or in the presence of renal failure, most probably because of the significantly elevated presepsin levels in non-infected patients. 28-d mortality rate was higher among patients with > 1277 pg/m L compared to those with ≤ 1277 pg/m L(46.9% vs 11.6%, P < 0.001). In a binary logistic regression analysis, however, only PCT(OR = 1.81, 95%CI: 1.09-3.01, P = 0.022) but neither presepsin nor CRP were independent risk factor for 28-d mortality after adjusting with MELD score and leukocyte count.CONCLUSION Presepsin is a valuable new biomarker for defining severe infections in cirrhosis, proving same efficacy as PCT. However, it is not a useful marker of short-term mortality.
AIM To evaluate the diagnostic and prognostic value of presepsin in cirrhosis-associated bacterial infections. METHODS Two hundred and sixteen patients with cirrhosis were enrolled. At admission, the presence of bacterial infections and level of plasma presepsin, serum C-reactive protein(CRP) and procalcitonin(PCT) were evaluated. Patients were followed for three months to assess the possible association between presepsin level and short-term mortality.RESULTS Present 34.7 of patients had bacterial infection. Presepsin levels were significantly higher in patients with infection than without(median, 1002 pg/m L vs 477 pg/m L, P < 0.001), increasing with the severity of infection [organ failure(OF): Yes vs No, 2358 pg/m L vs 710 pg/m L, P < 0.001]. Diagnostic accuracy of presepsin for severe infections was similar to PCT and superior to CRP(AUC-ROC: 0.85, 0.85 and 0.66, respectively, P = NS for presepsin vs PCT and P < 0.01 for presepsin vs CRP). At the optimal cut-off value of presepsin > 1206 pg/m L sensitivity, specificity, positive predictive values and negative predictive values were as follows: 87.5%, 74.5%, 61.8% and 92.7%. The accuracy of presepsin, however, decreased in advanced stage of the disease or in the presence of renal failure, most probably because of the significantly elevated presepsin levels in non-infected patients. 28-d mortality rate was higher among patients with > 1277 pg/m L compared to those with ≤ 1277 pg/m L(46.9% vs 11.6%, P < 0.001). In a binary logistic regression analysis, however, only PCT(OR = 1.81, 95%CI: 1.09-3.01, P = 0.022) but neither presepsin nor CRP were independent risk factor for 28-d mortality after adjusting with MELD score and leukocyte count.CONCLUSION Presepsin is a valuable new biomarker for defining severe infections in cirrhosis, proving same efficacy as PCT. However, it is not a useful marker of short-term mortality.
引文
1 Jalan R,Fernandez J,Wiest R,Schnabl B,Moreau R,Angeli P,Stadlbauer V,Gustot T,Bernardi M,Canton R,Albillos A,Lammert F,Wilmer A,Mookerjee R,Vila J,Garcia-Martinez R,Wendon J,Such J,Cordoba J,Sanyal A,Garcia-Tsao G,Arroyo V,Burroughs A,Ginès P.Bacterial infections in cirrhosis:a position statement based on the EASL Special Conference 2013.J Hepatol2014;60:1310-1324[PMID:24530646 DOI:10.1016/j.jhep.2014.01.024]Available]
2 Bajaj JS,O’Leary JG,Reddy KR,Wong F,Biggins SW,Patton H,Fallon MB,Garcia-Tsao G,Maliakkal B,Malik R,Subramanian RM,Thacker LR,Kamath PS.Survival in infection-related acuteon-chronic liver failure is defined by extrahepatic organ failures.Hepatology 2014;60:250-256[PMID:24677131 DOI:10.1002/hep.27077]
3 Moreau R,Jalan R,Gines P,Pavesi M,Angeli P,Cordoba J,Durand F,Gustot T,Saliba F,Domenicali M,Gerbes A,Wendon J,Alessandria C,Laleman W,Zeuzem S,Trebicka J,Bernardi M,Arroyo V.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.Gastroenterology 2013;144:1426-137,1426-137,[PMID:23474284 DOI:10.1053/j.gastro.2013.02.042]Available]
4 Wong F,Bernardi M,Balk R,Christman B,Moreau R,GarciaTsao G,Patch D,Soriano G,Hoefs J,Navasa M.Sepsis in cirrhosis:report on the 7th meeting of the International Ascites Club.Gut 2005;54:718-725[PMID:15831923 DOI:10.1136/gut.2004.038679]
5 Pieri G,Agarwal B,Burroughs AK.C-reactive protein and bacterial infection in cirrhosis.Ann Gastroenterol 2014;27:113-120[PMID:24733601]
6 Cazzaniga M,Dionigi E,Gobbo G,Fioretti A,Monti V,Salerno F.The systemic inflammatory response syndrome in cirrhotic patients:relationship with their in-hospital outcome.JHepatol 2009;51:475-482[PMID:19560225 DOI:10.1016/j.jhep.2009.04.017]
7 Bone RC,Balk RA,Cerra FB,Dellinger RP,Fein AM,Knaus WA,Schein RM,Sibbald WJ.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine.Chest 1992;101:1644-1655[PMID:1303622]
8 Gabay C,Kushner I.Acute-phase proteins and other systemic responses to inflammation.N Engl J Med 1999;340:448-454[PMID:9971870 DOI:10.1056/NEJM199902113400607]
9 Papp M,Vitalis Z,Altorjay I,Tornai I,Udvardy M,Harsfalvi J,Vida A,Kappelmayer J,Lakatos PL,Antal-Szalmas P.Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections.Liver Int 2012;32:603-611[DOI:10.1111/j.1478-3231.2011.02689.x]
10 Park WB,Lee KD,Lee CS,Jang HC,Kim HB,Lee HS,Oh MD,Choe KW.Production of C-reactive protein in Escherichia coliinfected patients with liver dysfunction due to liver cirrhosis.Diagn Microbiol Infect Dis 2005;51:227-230[PMID:15808312DOI:10.1016/j.diagmicrobio.2004.11.014]
11 Angeli P,Tonon M,Pilutti C,Morando F,Piano S.Sepsis-induced acute kidney injury in patients with cirrhosis.Hepatol Int 2016;10:115-123[PMID:26141259 DOI:10.1007/s12072-015-9641-1]
12 Westhuyzen J,Healy H.Review:Biology and relevance of C-reactive protein in cardiovascular and renal disease.Ann Clin Lab Sci 2000;30:133-143[PMID:10807156]
13 Vigushin DM,Pepys M B,Hawkins P N.Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.J Clin Invest 1993;91:1351-1357[PMID:8473487 DOI:10.1172/JCI116336]
14 Lu XL,Xiao ZH,Yang MY,Zhu YM.Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency:a systematic review and meta-analysis.Nephrol Dial Transplant2013;28:122-129[PMID:23045429 DOI:10.1093/ndt/gfs339]
15 Lee WS,Kang DW,Back JH,Kim HL,Chung JH,Shin BC.Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.Korean J Intern Med 2015;30:198-204[PMID:25750561 DOI:10.3904/kjim.2015.30.2.198]
16 El-Sayed D,Grotts J,Golgert WA,Sugar AM.Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment.Open Forum Infect Dis 2014;1:ofu068[PMID:25734138 DOI:10.1093/ofid/ofu068]
17 Caldini A,Chelazzi C,Terreni A,Biagioli T,Giannoni C,Villa G,Messeri G,De Gaudio AR.Is procalcitonin a reliable marker of sepsis in critically ill septic patients undergoing continuous venovenous hemodiafiltration with“high cut-off”membranes(HCO-CVVHDF)?Clin Chem Lab Med 2013;51:e261-e263[PMID:23787472 DOI:10.1515/cclm-2013-0257]
18 Wiest R,Lawson M,Geuking M.Pathological bacterial translocation in liver cirrhosis.J Hepatol 2014;60:197-209[PMID:23993913 DOI:10.1016/j.jhep.2013.07.044]
19 Lazzarotto C,Ronsoni MF,Fayad L,Nogueira CL,Bazzo ML,Narciso-Schiavon JL,de Lucca Schiavon L,Dantas-Corrêa EB.Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis.Ann Hepatol 2013;12:599-607[PMID:23813138]
20 Cervoni JP,Thévenot T,Weil D,Muel E,Barbot O,Sheppard F,Monnet E,Di Martino V.C-reactive protein predicts short-term mortality in patients with cirrhosis.J Hepatol 2012;56:1299-1304[PMID:22314431 DOI:10.1016/j.jhep.2011.12.030]
21 Li CH,Yang RB,Pang JH,Chang SS,Lin CC,Chen CH,Chen HY,Chiu TF.Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department.Acad Emerg Med 2011;18:121-126[PMID:21276124 DOI:10.1111/j.1553-2712.2010.00991.x]
22 Bota DP,Van Nuffelen M,Zakariah AN,Vincent JL.Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver.J Lab Clin Med 2005;146:347-351[PMID:16310518 DOI:10.1016/j.lab.2005.08.005]
23 Viallon A,Zeni F,Pouzet V,Lambert C,Quenet S,Aubert G,Guyomarch S,Tardy B,Bertrand JC.Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis:diagnostic value and relationship to pro-inflammatory cytokines.Intensive Care Med 2000;26:1082-1088[PMID:11030164]
24 Chenevier-Gobeaux C,Borderie D,Weiss N,Mallet-Coste T,Claessens YE.Presepsin(s CD14-ST),an innate immune response marker in sepsis.Clin Chim Acta 2015;450:97-103[PMID:26164388 DOI:10.1016/j.cca.2015.06.026]
25 Dupuy AM,Philippart F,Péan Y,Lasocki S,Charles PE,Chalumeau M,Claessens YE,Quenot JP,Guen CG,Ruiz S,Luyt CE,Roche N,Stahl JP,Bedos JP,Pugin J,Gauzit R,Misset B,Brun-Buisson C.Role of biomarkers in the management of antibiotic therapy:an expert panel review:I-currently available biomarkers for clinical use in acute infections.Ann Intensive Care2013;3:22[PMID:23837559 DOI:10.1186/2110-5820-3-22]
26 Tong X,Cao Y,Yu M,Han C.Presepsin as a diagnostic marker for sepsis:evidence from a bivariate meta-analysis.Ther Clin Risk Manag 2015;11:1027-1033[PMID:26170681 DOI:10.2147/TCRM.S84811]
27 Wu J,Hu L,Zhang G,Wu F,He T.Accuracy of Presepsin in Sepsis Diagnosis:A Systematic Review and Meta-Analysis.PLo SOne 2015;10:e0133057[PMID:26192602 DOI:10.1371/journal.pone.0133057]
28 Carey E,Carey WD.Noninvasive tests for liver disease,fibrosis,and cirrhosis:Is liver biopsy obsolete?Cleve Clin J Med 2010;77:519-527[PMID:20682514 DOI:10.3949/ccjm.77a.09138]
29 Durand F,Valla D.Assessment of the prognosis of cirrhosis:Child-Pugh versus MELD.J Hepatol 2005;42 Suppl:S100-S107[PMID:15777564 DOI:10.1016/j.jhep.2004.11.015]
30 Jalan R,Saliba F,Pavesi M,Amoros A,Moreau R,Ginès P,Levesque E,Durand F,Angeli P,Caraceni P,Hopf C,Alessandria C,Rodriguez E,Solis-Mu?oz P,Laleman W,Trebicka J,Zeuzem S,Gustot T,Mookerjee R,Elkrief L,Soriano G,Cordoba J,Morando F,Gerbes A,Agarwal B,Samuel D,Bernardi M,Arroyo V.Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.J Hepatol2014;61:1038-1047[DOI:10.1016/j.jhep.2014.06.012]
31 Mohan P,Ramu B,Bhaskar E,Venkataraman J.Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis.Ann Hepatol 2011;10:15-20[PMID:21301004]
32 Fernández J,Navasa M,Gómez J,Colmenero J,Vila J,Arroyo V,Rodés J.Bacterial infections in cirrhosis:epidemiological changes with invasive procedures and norfloxacin prophylaxis.Hepatology 2002;35:140-148[PMID:11786970 DOI:10.1053/jhep.2002.30082]
33 Cadranel JF,Denis J,Pauwels A,Barbare JC,Eugène C,di Martino V,Poquet E,Medini A,Coutarel P,Latrive JP,Lema?tre P,Devergie B.Prevalence and risk factors of bacteriuria in cirrhotic patients:a prospective case-control multicenter study in 244patients.J Hepatol 1999;31:464-468[PMID:10488705 DOI:10.1016/S0168-8278(99)80038-5]
34 European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis.JHepatol 2010;53:397-417[PMID:20633946 DOI:10.1016/j.jhep.2010.05.004]Available]
35 De Long ER,De Long DM,Clarke-Pearson DL.Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach.Biometrics 1988;44:837-845[PMID:3203132]
36 Tandon P,Garcia-Tsao G.Bacterial infections,sepsis,and multiorgan failure in cirrhosis.Semin Liver Dis 2008;28:26-42[PMID:18293275 DOI:10.1055/s-2008-1040319]
37 Thalheimer U,Triantos CK,Samonakis DN,Patch D,Burroughs AK.Infection,coagulation,and variceal bleeding in cirrhosis.Gut 2005;54:556-563[PMID:15753544 DOI:10.1136/gut.2004.048181]
38 Levy MM,Fink MP,Marshall JC,Abraham E,Angus D,Cook D,Cohen J,Opal SM,Vincent JL,Ramsay G.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med 2003;31:1250-1256[PMID:12682500 DOI:10.1097/01.CCM.0000050454.01978.3B]
39 Shozushima T,Takahashi G,Matsumoto N,Kojika M,Okamura Y,Endo S.Usefulness of presepsin(s CD14-ST)measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.J Infect Chemother 2011;17:764-769[PMID:21560033 DOI:10.1007/s10156-011-0254-x]
40 Ulla M,Pizzolato E,Lucchiari M,Loiacono M,Soardo F,Forno D,Morello F,Lupia E,Moiraghi C,Mengozzi G,Battista S.Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department:a multicenter prospective study.Crit Care 2013;17:R168[PMID:23899120 DOI:10.1186/cc12847]
41 Zheng Z,Jiang L,Ye L,Gao Y,Tang L,Zhang M.The accuracy of presepsin for the diagnosis of sepsis from SIRS:a systematic review and meta-analysis.Ann Intensive Care 2015;5:48[PMID:26642970 DOI:10.1186/s13613-015-0089-1]
42 Angeletti S,Spoto S,Fogolari M,Cortigiani M,Fioravanti M,De Florio L,Curcio B,Cavalieri D,Costantino S,Dicuonzo G.Diagnostic and prognostic role of procalcitonin(PCT)and MR-pro-Adrenomedullin(MR-pro ADM)in bacterial infections.APMIS2015;123:740-748[PMID:26058482 DOI:10.1111/apm.12406]
43 Leli C,Ferranti M,Moretti A,Al Dhahab ZS,Cenci E,Mencacci A.Procalcitonin levels in gram-positive,gram-negative,and fungal bloodstream infections.Dis Markers 2015;2015:701480[PMID:25852221 DOI:10.1155/2015/701480]
44 BrodskáH,Malí?kováK,AdámkováV,BenákováH,??astnáMM,Zima T.Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.Clin Exp Med 2013;13:165-170[PMID:22644264 DOI:10.1007/s10238-012-0191-8]
45 Charles PE,Ladoire S,Aho S,Quenot JP,Doise JM,Prin S,Olsson NO,Blettery B.Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria.BMC Infect Dis 2008;8:38[PMID:18366777 DOI:10.1186/1471-2334-8-38]
46 Xu XJ,Tang YM,Liao C,Song H,Yang SL,Xu WQ,Shi SW,Zhao N.Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock.Intensive Care Med 2013;39:319-326[PMID:23179333 DOI:10.1007/s00134-012-2752-4]
47 Huttunen R,Syrj?nen J,Vuento R,Hurme M,Huhtala H,Laine J,Pessi T,Aittoniemi J.Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia:a prospective cohort study.J Intern Med 2011;270:32-40[PMID:21332843 DOI:10.1111/j.1365-2796.2011.02363.x]
48 Ga?ni S,Pedersen SS,Koldkaer OG,Pedersen C,Moestrup SK,M?ller HJ.New immunological serum markers in bacteraemia:anti-inflammatory soluble CD163,but not proinflammatory high mobility group-box 1 protein,is related to prognosis.Clin Exp Immunol 2008;151:423-431[PMID:18190604 DOI:10.1111/j.1365-2249.2007.03586.x]
49 Burgmann H,Winkler S,Locker GJ,Presterl E,Laczika K,Staudinger T,Knapp S,Thalhammer F,Wenisch C,ZedwitzL i e b e n s t e i n K,F r a s s M,G r a n i n g e r W.I n c r e a s e d s e r u m concentration of soluble CD14 is a prognostic marker in grampositive sepsis.Clin Immunol Immunopathol 1996;80:307-310[PMID:8811052]
50 Tornai T,Vitalis Z,Sipeki N,Dinya T,Tornai D,Antal-Szalmas P,Karanyi Z,Tornai I,Papp M.Macrophage activation marker,soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.Liver Int 2016;Epub ahead of print[PMID:27031405 DOI:10.1111/liv.13133]
51 Endo S,Suzuki Y,Takahashi G,Shozushima T,Ishikura H,Murai A,Nishida T,Irie Y,Miura M,Iguchi H,Fukui Y,Tanaka K,Nojima T,Okamura Y.Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.J Infect Chemother 2012;18:891-897[PMID:22692596 DOI:10.1007/s10156-012-0435-2]
52 Enguix-Armada A,Escobar-Conesa R,García-De La Torre A,De La Torre-Prados MV.Usefulness of several biomarkers in the management of septic patients:C-reactive protein,procalcitonin,presepsin and mid-regional pro-adrenomedullin.Clin Chem Lab Med 2016;54:163-168[PMID:26083268 DOI:10.1515/cclm-2015-0243]
53 Plesko M,Suvada J,Makohusova M,Waczulikova I,Behulova D,Vasilenkova A,Vargova M,Stecova A,Kaiserova E,Kolenova A.The role of CRP,PCT,IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haematooncological patients.Neoplasma 2016;63:752-760[PMID:27468879 DOI:10.4149/neo_2016_512]
54 Albillos A,de la Hera A,González M,Moya JL,Calleja JL,Monserrat J,Ruiz-del-Arbol L,Alvarez-Mon M.Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.Hepatology 2003;37:208-217[PMID:12500206 DOI:10.1053/jhep.2003.50038]
55 Márquez M,Fernández-Gutiérrez C,Montes-de-Oca M,Blanco MJ,Brun F,Rodríguez-Ramos C,Girón-González JA.Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis.Clin Exp Immunol 2009;158:219-229[PMID:19737142 DOI:10.1111/j.1365-2249.2009.04005.x]
56 Cirera I,Bauer TM,Navasa M,Vila J,Grande L,TauráP,Fuster J,García-Valdecasas JC,Lacy A,Suárez MJ,Rimola A,Rodés J.Bacterial translocation of enteric organisms in patients with cirrhosis.J Hepatol 2001;34:32-37[PMID:11211904]
57 Garcia-Tsao G,Lee FY,Barden GE,Cartun R,West AB.Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites.Gastroenterology 1995;108:1835-1841[PMID:7768390]
58 Okamura Y,Yokoi H.Development of a point-of-care assay system for measurement of presepsin(s CD14-ST).Clin Chim Acta 2011;412:2157-2161[PMID:21839732 DOI:10.1016/j.cca.2011.07.024]
59 Regner KR,Singbartl K.Kidney Injury in Liver Disease.Crit Care Clin 2016;32:343-355[PMID:27339675 DOI:10.1016/j.ccc.2016.03.005]
60 Chenevier-Gobeaux C,Trabattoni E,Roelens M,Borderie D,Claessens YE.Presepsin(s CD14-ST)in emergency department:the need for adapted threshold values?Clin Chim Acta 2014;427:34-36[PMID:24076253 DOI:10.1016/j.cca.2013.09.019]
61 Nagata T,Yasuda Y,Ando M,Abe T,Katsuno T,Kato S,Tsuboi N,Matsuo S,Maruyama S.Clinical impact of kidney function on presepsin levels.PLo S One 2015;10:e0129159[PMID:26030716DOI:10.1371/journal.pone.0129159]
62 Nakamura Y,Ishikura H,Nishida T,Kawano Y,Yuge R,Ichiki R,Murai A.Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury.BMC Anesthesiol2014;14:88[PMID:25309126 DOI:10.1186/1471-2253-14-88]
63 Cervoni JP,Amorósà,Ba?ares R,Luis Montero J,Soriano G,Weil D,Moreau R,Pavesi M,Thévenot T,Di Martino V.Prognostic value of C-reactive protein in cirrhosis:external validation from the CANONIC cohort.Eur J Gastroenterol Hepatol 2016;28:1028-1034[PMID:27271159 DOI:10.1097/MEG.0000000000000676]
64 Di Martino V,Coutris C,Cervoni JP,Dritsas S,Weil D,Richou C,Vanlemmens C,Thevenot T.Prognostic value of C-reactive protein levels in patients with cirrhosis.Liver Transpl 2015;21:753-760[PMID:25677965 DOI:10.1002/lt.24088]
65 Ha YE,Kang CI,Joo EJ,Joung MK,Chung DR,Peck KR,Lee NY,Song JH.Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremia.Korean JIntern Med 2011;26:195-200[PMID:21716910 DOI:10.3904/kjim.2011.26.2.195]
66 Kronenberger B,Rudloff I,Bachmann M,Brunner F,Kapper L,Filmann N,Waidmann O,Herrmann E,Pfeilschifter J,Zeuzem S,Piiper A,Mühl H.Interleukin-22 predicts severity and death in advanced liver cirrhosis:a prospective cohort study.BMC Med2012;10:102[PMID:22967278 DOI:10.1186/1741-7015-10-102]
67 Kwon JH,Jang JW,Kim YW,Lee SW,Nam SW,Jaegal D,Lee S,Bae SH.The usefulness of C-reactive protein and neutrophilto-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.BMC Gastroenterol 2015;15:146[PMID:26498833 DOI:10.1186/s12876-015-0378-z]
68 Lim TS,Kim BK,Lee JW,Lee YK,Chang S,Kim SU,Kim DY,Ahn SH,Han KH,Chon CY,Park JY.Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis:implications of a simple and useful marker.PLo S One 2014;9:e86884[PMID:24466280 DOI:10.1371/journal.pone.0086884]
69 Moreno JP,Grandclement E,Monnet E,Clerc B,Agin A,Cervoni JP,Richou C,Vanlemmens C,Dritsas S,Dumoulin G,Di Martino V,Thevenot T.Plasma copeptin,a possible prognostic marker in cirrhosis.Liver Int 2013;33:843-851[PMID:23560938 DOI:10.1111/liv.12175]
70 Mortensen C,Andersen O,Krag A,Bendtsen F,M?ller S.Highsensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis.Eur J Gastroenterol Hepatol 2012;24:619-626[PMID:22441510 DOI:10.1097/MEG.0b013e328351db6e]
71 Park JK,Lee CH,Kim IH,Kim SM,Jang JW,Kim SH,Kim SW,Lee SO,Lee ST,Kim DG.Clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease.J Korean Med Sci 2015;30:598-605[PMID:25931791 DOI:10.3346/jkms.2015.30.5.598]
72 Reuken PA,Stallmach A,Bruns T.Mortality after urinary tract infections in patients with advanced cirrhosis-Relevance of acute kidney injury and comorbidities.Liver Int 2013;33:220-230[PMID:23295053 DOI:10.1111/liv.12029]
73 Schwabl P,Bucsics T,Soucek K,Mandorfer M,Bota S,Blacky A,Hirschl AM,Ferlitsch A,Trauner M,Peck-Radosavljevic M,Reiberger T.Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.Liver Int 2015;35:2121-2128[PMID:25644943 DOI:10.1111/liv.12795]
74 Wiese S,Mortensen C,G?tze JP,Christensen E,Andersen O,Bendtsen F,M?ller S.Cardiac and proinflammatory markers predict prognosis in cirrhosis.Liver Int 2014;34:e19-e30[PMID:24313898 DOI:10.1111/liv.12428]
75 Ximenes RO,Farias AQ,Scalabrini Neto A,Diniz MA,Kubota GT,Ivo MM,Colacique CG,D’Albuquerque LA,Daglius Dias R.Patients with cirrhosis in the ED:early predictors of infection and mortality.Am J Emerg Med 2016;34:25-29[PMID:26423777DOI:10.1016/j.ajem.2015.09.004]
76 Al-Dorzi HM,Rishu AH,Tamim HM,Aljumah A,Al-Tamimi W,Baharoon S,Al Dabbagh T,Arabi YM.Serum procalcitonin in cirrhotic patients with septic shock:relationship with adrenal insufficiency and clinical outcomes.Clin Lab 2014;60:1105-1114[PMID:25134378]
77 Berres ML,Schnyder B,Yagmur E,Inglis B,Stanzel S,Tischendorf JJ,Koch A,Winograd R,Trautwein C,Wasmuth HE.Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis.Liver Int 2009;29:536-543[PMID:18795898DOI:10.1111/j.1478-3231.2008.01870.x]
78 Connert S,Stremmel W,Elsing C.Procalcitonin is a valid marker of infection in decompensated cirrhosis.Z Gastroenterol 2003;41:165-170[PMID:12592597 DOI:10.1055/s-2003-37314]
79 Kotecha HL,Arora A,Chawlani R,Toshniwal J,Bansal N,Tyagi P,Sharma P,Kumar M,Kumar A.Low eosinophil count predicts inhospital mortality in cirrhosis with systemic inflammatory response syndrome.Eur J Gastroenterol Hepatol 2013;25:676-682[PMID:23411865 DOI:10.1097/MEG.0b013e32835eb8f7]
80 Lin S,Huang Z,Wang M,Weng Z,Zeng D,Zhang Y,Zhu Y,Jiang J.Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis.J Crit Care 2015;30:732-738[PMID:25891645 DOI:10.1016/j.jcrc.2015.03.031]
81 Müller B,White JC,Nylén ES,Snider RH,Becker KL,Habener JF.Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis.J Clin Endocrinol Metab 2001;86:396-404[PMID:11232031 DOI:10.1210/jcem.86.1.7089]
82 Matwiyoff GN,Prahl JD,Miller RJ,Carmichael JJ,Amundson DE,Seda G,Daheshia M.Immune regulation of procalcitonin:a biomarker and mediator of infection.Inflamm Res 2012;61:401-409[PMID:22354317 DOI:10.1007/s00011-012-0439-5]
83 Nylen ES,Whang KT,Snider RH,Steinwald PM,White JC,Becker KL.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.Crit Care Med 1998;26:1001-1006[PMID:9635646]
84 Sica A,Mantovani A.Macrophage plasticity and polarization:in vivo veritas.J Clin Invest 2012;122:787-795[PMID:22378047DOI:10.1172/JCI59643]
2 Bajaj JS,O’Leary JG,Reddy KR,Wong F,Biggins SW,Patton H,Fallon MB,Garcia-Tsao G,Maliakkal B,Malik R,Subramanian RM,Thacker LR,Kamath PS.Survival in infection-related acuteon-chronic liver failure is defined by extrahepatic organ failures.Hepatology 2014;60:250-256[PMID:24677131 DOI:10.1002/hep.27077]
3 Moreau R,Jalan R,Gines P,Pavesi M,Angeli P,Cordoba J,Durand F,Gustot T,Saliba F,Domenicali M,Gerbes A,Wendon J,Alessandria C,Laleman W,Zeuzem S,Trebicka J,Bernardi M,Arroyo V.Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis.Gastroenterology 2013;144:1426-137,1426-137,[PMID:23474284 DOI:10.1053/j.gastro.2013.02.042]Available]
4 Wong F,Bernardi M,Balk R,Christman B,Moreau R,GarciaTsao G,Patch D,Soriano G,Hoefs J,Navasa M.Sepsis in cirrhosis:report on the 7th meeting of the International Ascites Club.Gut 2005;54:718-725[PMID:15831923 DOI:10.1136/gut.2004.038679]
5 Pieri G,Agarwal B,Burroughs AK.C-reactive protein and bacterial infection in cirrhosis.Ann Gastroenterol 2014;27:113-120[PMID:24733601]
6 Cazzaniga M,Dionigi E,Gobbo G,Fioretti A,Monti V,Salerno F.The systemic inflammatory response syndrome in cirrhotic patients:relationship with their in-hospital outcome.JHepatol 2009;51:475-482[PMID:19560225 DOI:10.1016/j.jhep.2009.04.017]
7 Bone RC,Balk RA,Cerra FB,Dellinger RP,Fein AM,Knaus WA,Schein RM,Sibbald WJ.Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis.The ACCP/SCCM Consensus Conference Committee.American College of Chest Physicians/Society of Critical Care Medicine.Chest 1992;101:1644-1655[PMID:1303622]
8 Gabay C,Kushner I.Acute-phase proteins and other systemic responses to inflammation.N Engl J Med 1999;340:448-454[PMID:9971870 DOI:10.1056/NEJM199902113400607]
9 Papp M,Vitalis Z,Altorjay I,Tornai I,Udvardy M,Harsfalvi J,Vida A,Kappelmayer J,Lakatos PL,Antal-Szalmas P.Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections.Liver Int 2012;32:603-611[DOI:10.1111/j.1478-3231.2011.02689.x]
10 Park WB,Lee KD,Lee CS,Jang HC,Kim HB,Lee HS,Oh MD,Choe KW.Production of C-reactive protein in Escherichia coliinfected patients with liver dysfunction due to liver cirrhosis.Diagn Microbiol Infect Dis 2005;51:227-230[PMID:15808312DOI:10.1016/j.diagmicrobio.2004.11.014]
11 Angeli P,Tonon M,Pilutti C,Morando F,Piano S.Sepsis-induced acute kidney injury in patients with cirrhosis.Hepatol Int 2016;10:115-123[PMID:26141259 DOI:10.1007/s12072-015-9641-1]
12 Westhuyzen J,Healy H.Review:Biology and relevance of C-reactive protein in cardiovascular and renal disease.Ann Clin Lab Sci 2000;30:133-143[PMID:10807156]
13 Vigushin DM,Pepys M B,Hawkins P N.Metabolic and scintigraphic studies of radioiodinated human C-reactive protein in health and disease.J Clin Invest 1993;91:1351-1357[PMID:8473487 DOI:10.1172/JCI116336]
14 Lu XL,Xiao ZH,Yang MY,Zhu YM.Diagnostic value of serum procalcitonin in patients with chronic renal insufficiency:a systematic review and meta-analysis.Nephrol Dial Transplant2013;28:122-129[PMID:23045429 DOI:10.1093/ndt/gfs339]
15 Lee WS,Kang DW,Back JH,Kim HL,Chung JH,Shin BC.Cutoff value of serum procalcitonin as a diagnostic biomarker of infection in end-stage renal disease patients.Korean J Intern Med 2015;30:198-204[PMID:25750561 DOI:10.3904/kjim.2015.30.2.198]
16 El-Sayed D,Grotts J,Golgert WA,Sugar AM.Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment.Open Forum Infect Dis 2014;1:ofu068[PMID:25734138 DOI:10.1093/ofid/ofu068]
17 Caldini A,Chelazzi C,Terreni A,Biagioli T,Giannoni C,Villa G,Messeri G,De Gaudio AR.Is procalcitonin a reliable marker of sepsis in critically ill septic patients undergoing continuous venovenous hemodiafiltration with“high cut-off”membranes(HCO-CVVHDF)?Clin Chem Lab Med 2013;51:e261-e263[PMID:23787472 DOI:10.1515/cclm-2013-0257]
18 Wiest R,Lawson M,Geuking M.Pathological bacterial translocation in liver cirrhosis.J Hepatol 2014;60:197-209[PMID:23993913 DOI:10.1016/j.jhep.2013.07.044]
19 Lazzarotto C,Ronsoni MF,Fayad L,Nogueira CL,Bazzo ML,Narciso-Schiavon JL,de Lucca Schiavon L,Dantas-Corrêa EB.Acute phase proteins for the diagnosis of bacterial infection and prediction of mortality in acute complications of cirrhosis.Ann Hepatol 2013;12:599-607[PMID:23813138]
20 Cervoni JP,Thévenot T,Weil D,Muel E,Barbot O,Sheppard F,Monnet E,Di Martino V.C-reactive protein predicts short-term mortality in patients with cirrhosis.J Hepatol 2012;56:1299-1304[PMID:22314431 DOI:10.1016/j.jhep.2011.12.030]
21 Li CH,Yang RB,Pang JH,Chang SS,Lin CC,Chen CH,Chen HY,Chiu TF.Procalcitonin as a biomarker for bacterial infections in patients with liver cirrhosis in the emergency department.Acad Emerg Med 2011;18:121-126[PMID:21276124 DOI:10.1111/j.1553-2712.2010.00991.x]
22 Bota DP,Van Nuffelen M,Zakariah AN,Vincent JL.Serum levels of C-reactive protein and procalcitonin in critically ill patients with cirrhosis of the liver.J Lab Clin Med 2005;146:347-351[PMID:16310518 DOI:10.1016/j.lab.2005.08.005]
23 Viallon A,Zeni F,Pouzet V,Lambert C,Quenet S,Aubert G,Guyomarch S,Tardy B,Bertrand JC.Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis:diagnostic value and relationship to pro-inflammatory cytokines.Intensive Care Med 2000;26:1082-1088[PMID:11030164]
24 Chenevier-Gobeaux C,Borderie D,Weiss N,Mallet-Coste T,Claessens YE.Presepsin(s CD14-ST),an innate immune response marker in sepsis.Clin Chim Acta 2015;450:97-103[PMID:26164388 DOI:10.1016/j.cca.2015.06.026]
25 Dupuy AM,Philippart F,Péan Y,Lasocki S,Charles PE,Chalumeau M,Claessens YE,Quenot JP,Guen CG,Ruiz S,Luyt CE,Roche N,Stahl JP,Bedos JP,Pugin J,Gauzit R,Misset B,Brun-Buisson C.Role of biomarkers in the management of antibiotic therapy:an expert panel review:I-currently available biomarkers for clinical use in acute infections.Ann Intensive Care2013;3:22[PMID:23837559 DOI:10.1186/2110-5820-3-22]
26 Tong X,Cao Y,Yu M,Han C.Presepsin as a diagnostic marker for sepsis:evidence from a bivariate meta-analysis.Ther Clin Risk Manag 2015;11:1027-1033[PMID:26170681 DOI:10.2147/TCRM.S84811]
27 Wu J,Hu L,Zhang G,Wu F,He T.Accuracy of Presepsin in Sepsis Diagnosis:A Systematic Review and Meta-Analysis.PLo SOne 2015;10:e0133057[PMID:26192602 DOI:10.1371/journal.pone.0133057]
28 Carey E,Carey WD.Noninvasive tests for liver disease,fibrosis,and cirrhosis:Is liver biopsy obsolete?Cleve Clin J Med 2010;77:519-527[PMID:20682514 DOI:10.3949/ccjm.77a.09138]
29 Durand F,Valla D.Assessment of the prognosis of cirrhosis:Child-Pugh versus MELD.J Hepatol 2005;42 Suppl:S100-S107[PMID:15777564 DOI:10.1016/j.jhep.2004.11.015]
30 Jalan R,Saliba F,Pavesi M,Amoros A,Moreau R,Ginès P,Levesque E,Durand F,Angeli P,Caraceni P,Hopf C,Alessandria C,Rodriguez E,Solis-Mu?oz P,Laleman W,Trebicka J,Zeuzem S,Gustot T,Mookerjee R,Elkrief L,Soriano G,Cordoba J,Morando F,Gerbes A,Agarwal B,Samuel D,Bernardi M,Arroyo V.Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.J Hepatol2014;61:1038-1047[DOI:10.1016/j.jhep.2014.06.012]
31 Mohan P,Ramu B,Bhaskar E,Venkataraman J.Prevalence and risk factors for bacterial skin infection and mortality in cirrhosis.Ann Hepatol 2011;10:15-20[PMID:21301004]
32 Fernández J,Navasa M,Gómez J,Colmenero J,Vila J,Arroyo V,Rodés J.Bacterial infections in cirrhosis:epidemiological changes with invasive procedures and norfloxacin prophylaxis.Hepatology 2002;35:140-148[PMID:11786970 DOI:10.1053/jhep.2002.30082]
33 Cadranel JF,Denis J,Pauwels A,Barbare JC,Eugène C,di Martino V,Poquet E,Medini A,Coutarel P,Latrive JP,Lema?tre P,Devergie B.Prevalence and risk factors of bacteriuria in cirrhotic patients:a prospective case-control multicenter study in 244patients.J Hepatol 1999;31:464-468[PMID:10488705 DOI:10.1016/S0168-8278(99)80038-5]
34 European Association for the Study of the Liver.EASL clinical practice guidelines on the management of ascites,spontaneous bacterial peritonitis,and hepatorenal syndrome in cirrhosis.JHepatol 2010;53:397-417[PMID:20633946 DOI:10.1016/j.jhep.2010.05.004]Available]
35 De Long ER,De Long DM,Clarke-Pearson DL.Comparing the areas under two or more correlated receiver operating characteristic curves:a nonparametric approach.Biometrics 1988;44:837-845[PMID:3203132]
36 Tandon P,Garcia-Tsao G.Bacterial infections,sepsis,and multiorgan failure in cirrhosis.Semin Liver Dis 2008;28:26-42[PMID:18293275 DOI:10.1055/s-2008-1040319]
37 Thalheimer U,Triantos CK,Samonakis DN,Patch D,Burroughs AK.Infection,coagulation,and variceal bleeding in cirrhosis.Gut 2005;54:556-563[PMID:15753544 DOI:10.1136/gut.2004.048181]
38 Levy MM,Fink MP,Marshall JC,Abraham E,Angus D,Cook D,Cohen J,Opal SM,Vincent JL,Ramsay G.2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.Crit Care Med 2003;31:1250-1256[PMID:12682500 DOI:10.1097/01.CCM.0000050454.01978.3B]
39 Shozushima T,Takahashi G,Matsumoto N,Kojika M,Okamura Y,Endo S.Usefulness of presepsin(s CD14-ST)measurements as a marker for the diagnosis and severity of sepsis that satisfied diagnostic criteria of systemic inflammatory response syndrome.J Infect Chemother 2011;17:764-769[PMID:21560033 DOI:10.1007/s10156-011-0254-x]
40 Ulla M,Pizzolato E,Lucchiari M,Loiacono M,Soardo F,Forno D,Morello F,Lupia E,Moiraghi C,Mengozzi G,Battista S.Diagnostic and prognostic value of presepsin in the management of sepsis in the emergency department:a multicenter prospective study.Crit Care 2013;17:R168[PMID:23899120 DOI:10.1186/cc12847]
41 Zheng Z,Jiang L,Ye L,Gao Y,Tang L,Zhang M.The accuracy of presepsin for the diagnosis of sepsis from SIRS:a systematic review and meta-analysis.Ann Intensive Care 2015;5:48[PMID:26642970 DOI:10.1186/s13613-015-0089-1]
42 Angeletti S,Spoto S,Fogolari M,Cortigiani M,Fioravanti M,De Florio L,Curcio B,Cavalieri D,Costantino S,Dicuonzo G.Diagnostic and prognostic role of procalcitonin(PCT)and MR-pro-Adrenomedullin(MR-pro ADM)in bacterial infections.APMIS2015;123:740-748[PMID:26058482 DOI:10.1111/apm.12406]
43 Leli C,Ferranti M,Moretti A,Al Dhahab ZS,Cenci E,Mencacci A.Procalcitonin levels in gram-positive,gram-negative,and fungal bloodstream infections.Dis Markers 2015;2015:701480[PMID:25852221 DOI:10.1155/2015/701480]
44 BrodskáH,Malí?kováK,AdámkováV,BenákováH,??astnáMM,Zima T.Significantly higher procalcitonin levels could differentiate Gram-negative sepsis from Gram-positive and fungal sepsis.Clin Exp Med 2013;13:165-170[PMID:22644264 DOI:10.1007/s10238-012-0191-8]
45 Charles PE,Ladoire S,Aho S,Quenot JP,Doise JM,Prin S,Olsson NO,Blettery B.Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria.BMC Infect Dis 2008;8:38[PMID:18366777 DOI:10.1186/1471-2334-8-38]
46 Xu XJ,Tang YM,Liao C,Song H,Yang SL,Xu WQ,Shi SW,Zhao N.Inflammatory cytokine measurement quickly discriminates gram-negative from gram-positive bacteremia in pediatric hematology/oncology patients with septic shock.Intensive Care Med 2013;39:319-326[PMID:23179333 DOI:10.1007/s00134-012-2752-4]
47 Huttunen R,Syrj?nen J,Vuento R,Hurme M,Huhtala H,Laine J,Pessi T,Aittoniemi J.Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia:a prospective cohort study.J Intern Med 2011;270:32-40[PMID:21332843 DOI:10.1111/j.1365-2796.2011.02363.x]
48 Ga?ni S,Pedersen SS,Koldkaer OG,Pedersen C,Moestrup SK,M?ller HJ.New immunological serum markers in bacteraemia:anti-inflammatory soluble CD163,but not proinflammatory high mobility group-box 1 protein,is related to prognosis.Clin Exp Immunol 2008;151:423-431[PMID:18190604 DOI:10.1111/j.1365-2249.2007.03586.x]
49 Burgmann H,Winkler S,Locker GJ,Presterl E,Laczika K,Staudinger T,Knapp S,Thalhammer F,Wenisch C,ZedwitzL i e b e n s t e i n K,F r a s s M,G r a n i n g e r W.I n c r e a s e d s e r u m concentration of soluble CD14 is a prognostic marker in grampositive sepsis.Clin Immunol Immunopathol 1996;80:307-310[PMID:8811052]
50 Tornai T,Vitalis Z,Sipeki N,Dinya T,Tornai D,Antal-Szalmas P,Karanyi Z,Tornai I,Papp M.Macrophage activation marker,soluble CD163 is an independent predictor of short-term mortality in patients with cirrhosis and bacterial infection.Liver Int 2016;Epub ahead of print[PMID:27031405 DOI:10.1111/liv.13133]
51 Endo S,Suzuki Y,Takahashi G,Shozushima T,Ishikura H,Murai A,Nishida T,Irie Y,Miura M,Iguchi H,Fukui Y,Tanaka K,Nojima T,Okamura Y.Usefulness of presepsin in the diagnosis of sepsis in a multicenter prospective study.J Infect Chemother 2012;18:891-897[PMID:22692596 DOI:10.1007/s10156-012-0435-2]
52 Enguix-Armada A,Escobar-Conesa R,García-De La Torre A,De La Torre-Prados MV.Usefulness of several biomarkers in the management of septic patients:C-reactive protein,procalcitonin,presepsin and mid-regional pro-adrenomedullin.Clin Chem Lab Med 2016;54:163-168[PMID:26083268 DOI:10.1515/cclm-2015-0243]
53 Plesko M,Suvada J,Makohusova M,Waczulikova I,Behulova D,Vasilenkova A,Vargova M,Stecova A,Kaiserova E,Kolenova A.The role of CRP,PCT,IL-6 and presepsin in early diagnosis of bacterial infectious complications in paediatric haematooncological patients.Neoplasma 2016;63:752-760[PMID:27468879 DOI:10.4149/neo_2016_512]
54 Albillos A,de la Hera A,González M,Moya JL,Calleja JL,Monserrat J,Ruiz-del-Arbol L,Alvarez-Mon M.Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.Hepatology 2003;37:208-217[PMID:12500206 DOI:10.1053/jhep.2003.50038]
55 Márquez M,Fernández-Gutiérrez C,Montes-de-Oca M,Blanco MJ,Brun F,Rodríguez-Ramos C,Girón-González JA.Chronic antigenic stimuli as a possible explanation for the immunodepression caused by liver cirrhosis.Clin Exp Immunol 2009;158:219-229[PMID:19737142 DOI:10.1111/j.1365-2249.2009.04005.x]
56 Cirera I,Bauer TM,Navasa M,Vila J,Grande L,TauráP,Fuster J,García-Valdecasas JC,Lacy A,Suárez MJ,Rimola A,Rodés J.Bacterial translocation of enteric organisms in patients with cirrhosis.J Hepatol 2001;34:32-37[PMID:11211904]
57 Garcia-Tsao G,Lee FY,Barden GE,Cartun R,West AB.Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites.Gastroenterology 1995;108:1835-1841[PMID:7768390]
58 Okamura Y,Yokoi H.Development of a point-of-care assay system for measurement of presepsin(s CD14-ST).Clin Chim Acta 2011;412:2157-2161[PMID:21839732 DOI:10.1016/j.cca.2011.07.024]
59 Regner KR,Singbartl K.Kidney Injury in Liver Disease.Crit Care Clin 2016;32:343-355[PMID:27339675 DOI:10.1016/j.ccc.2016.03.005]
60 Chenevier-Gobeaux C,Trabattoni E,Roelens M,Borderie D,Claessens YE.Presepsin(s CD14-ST)in emergency department:the need for adapted threshold values?Clin Chim Acta 2014;427:34-36[PMID:24076253 DOI:10.1016/j.cca.2013.09.019]
61 Nagata T,Yasuda Y,Ando M,Abe T,Katsuno T,Kato S,Tsuboi N,Matsuo S,Maruyama S.Clinical impact of kidney function on presepsin levels.PLo S One 2015;10:e0129159[PMID:26030716DOI:10.1371/journal.pone.0129159]
62 Nakamura Y,Ishikura H,Nishida T,Kawano Y,Yuge R,Ichiki R,Murai A.Usefulness of presepsin in the diagnosis of sepsis in patients with or without acute kidney injury.BMC Anesthesiol2014;14:88[PMID:25309126 DOI:10.1186/1471-2253-14-88]
63 Cervoni JP,Amorósà,Ba?ares R,Luis Montero J,Soriano G,Weil D,Moreau R,Pavesi M,Thévenot T,Di Martino V.Prognostic value of C-reactive protein in cirrhosis:external validation from the CANONIC cohort.Eur J Gastroenterol Hepatol 2016;28:1028-1034[PMID:27271159 DOI:10.1097/MEG.0000000000000676]
64 Di Martino V,Coutris C,Cervoni JP,Dritsas S,Weil D,Richou C,Vanlemmens C,Thevenot T.Prognostic value of C-reactive protein levels in patients with cirrhosis.Liver Transpl 2015;21:753-760[PMID:25677965 DOI:10.1002/lt.24088]
65 Ha YE,Kang CI,Joo EJ,Joung MK,Chung DR,Peck KR,Lee NY,Song JH.Usefulness of C-reactive protein for evaluating clinical outcomes in cirrhotic patients with bacteremia.Korean JIntern Med 2011;26:195-200[PMID:21716910 DOI:10.3904/kjim.2011.26.2.195]
66 Kronenberger B,Rudloff I,Bachmann M,Brunner F,Kapper L,Filmann N,Waidmann O,Herrmann E,Pfeilschifter J,Zeuzem S,Piiper A,Mühl H.Interleukin-22 predicts severity and death in advanced liver cirrhosis:a prospective cohort study.BMC Med2012;10:102[PMID:22967278 DOI:10.1186/1741-7015-10-102]
67 Kwon JH,Jang JW,Kim YW,Lee SW,Nam SW,Jaegal D,Lee S,Bae SH.The usefulness of C-reactive protein and neutrophilto-lymphocyte ratio for predicting the outcome in hospitalized patients with liver cirrhosis.BMC Gastroenterol 2015;15:146[PMID:26498833 DOI:10.1186/s12876-015-0378-z]
68 Lim TS,Kim BK,Lee JW,Lee YK,Chang S,Kim SU,Kim DY,Ahn SH,Han KH,Chon CY,Park JY.Use of the delta neutrophil index as a prognostic factor of mortality in patients with spontaneous bacterial peritonitis:implications of a simple and useful marker.PLo S One 2014;9:e86884[PMID:24466280 DOI:10.1371/journal.pone.0086884]
69 Moreno JP,Grandclement E,Monnet E,Clerc B,Agin A,Cervoni JP,Richou C,Vanlemmens C,Dritsas S,Dumoulin G,Di Martino V,Thevenot T.Plasma copeptin,a possible prognostic marker in cirrhosis.Liver Int 2013;33:843-851[PMID:23560938 DOI:10.1111/liv.12175]
70 Mortensen C,Andersen O,Krag A,Bendtsen F,M?ller S.Highsensitivity C-reactive protein levels predict survival and are related to haemodynamics in alcoholic cirrhosis.Eur J Gastroenterol Hepatol 2012;24:619-626[PMID:22441510 DOI:10.1097/MEG.0b013e328351db6e]
71 Park JK,Lee CH,Kim IH,Kim SM,Jang JW,Kim SH,Kim SW,Lee SO,Lee ST,Kim DG.Clinical characteristics and prognostic impact of bacterial infection in hospitalized patients with alcoholic liver disease.J Korean Med Sci 2015;30:598-605[PMID:25931791 DOI:10.3346/jkms.2015.30.5.598]
72 Reuken PA,Stallmach A,Bruns T.Mortality after urinary tract infections in patients with advanced cirrhosis-Relevance of acute kidney injury and comorbidities.Liver Int 2013;33:220-230[PMID:23295053 DOI:10.1111/liv.12029]
73 Schwabl P,Bucsics T,Soucek K,Mandorfer M,Bota S,Blacky A,Hirschl AM,Ferlitsch A,Trauner M,Peck-Radosavljevic M,Reiberger T.Risk factors for development of spontaneous bacterial peritonitis and subsequent mortality in cirrhotic patients with ascites.Liver Int 2015;35:2121-2128[PMID:25644943 DOI:10.1111/liv.12795]
74 Wiese S,Mortensen C,G?tze JP,Christensen E,Andersen O,Bendtsen F,M?ller S.Cardiac and proinflammatory markers predict prognosis in cirrhosis.Liver Int 2014;34:e19-e30[PMID:24313898 DOI:10.1111/liv.12428]
75 Ximenes RO,Farias AQ,Scalabrini Neto A,Diniz MA,Kubota GT,Ivo MM,Colacique CG,D’Albuquerque LA,Daglius Dias R.Patients with cirrhosis in the ED:early predictors of infection and mortality.Am J Emerg Med 2016;34:25-29[PMID:26423777DOI:10.1016/j.ajem.2015.09.004]
76 Al-Dorzi HM,Rishu AH,Tamim HM,Aljumah A,Al-Tamimi W,Baharoon S,Al Dabbagh T,Arabi YM.Serum procalcitonin in cirrhotic patients with septic shock:relationship with adrenal insufficiency and clinical outcomes.Clin Lab 2014;60:1105-1114[PMID:25134378]
77 Berres ML,Schnyder B,Yagmur E,Inglis B,Stanzel S,Tischendorf JJ,Koch A,Winograd R,Trautwein C,Wasmuth HE.Longitudinal monocyte human leukocyte antigen-DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis.Liver Int 2009;29:536-543[PMID:18795898DOI:10.1111/j.1478-3231.2008.01870.x]
78 Connert S,Stremmel W,Elsing C.Procalcitonin is a valid marker of infection in decompensated cirrhosis.Z Gastroenterol 2003;41:165-170[PMID:12592597 DOI:10.1055/s-2003-37314]
79 Kotecha HL,Arora A,Chawlani R,Toshniwal J,Bansal N,Tyagi P,Sharma P,Kumar M,Kumar A.Low eosinophil count predicts inhospital mortality in cirrhosis with systemic inflammatory response syndrome.Eur J Gastroenterol Hepatol 2013;25:676-682[PMID:23411865 DOI:10.1097/MEG.0b013e32835eb8f7]
80 Lin S,Huang Z,Wang M,Weng Z,Zeng D,Zhang Y,Zhu Y,Jiang J.Interleukin-6 as an early diagnostic marker for bacterial sepsis in patients with liver cirrhosis.J Crit Care 2015;30:732-738[PMID:25891645 DOI:10.1016/j.jcrc.2015.03.031]
81 Müller B,White JC,Nylén ES,Snider RH,Becker KL,Habener JF.Ubiquitous expression of the calcitonin-i gene in multiple tissues in response to sepsis.J Clin Endocrinol Metab 2001;86:396-404[PMID:11232031 DOI:10.1210/jcem.86.1.7089]
82 Matwiyoff GN,Prahl JD,Miller RJ,Carmichael JJ,Amundson DE,Seda G,Daheshia M.Immune regulation of procalcitonin:a biomarker and mediator of infection.Inflamm Res 2012;61:401-409[PMID:22354317 DOI:10.1007/s00011-012-0439-5]
83 Nylen ES,Whang KT,Snider RH,Steinwald PM,White JC,Becker KL.Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis.Crit Care Med 1998;26:1001-1006[PMID:9635646]
84 Sica A,Mantovani A.Macrophage plasticity and polarization:in vivo veritas.J Clin Invest 2012;122:787-795[PMID:22378047DOI:10.1172/JCI59643]